SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hunter Biden’s Laptop (LAPTOP) is a memecoin referencing the eponymous Hunter Biden laptop sensation that’s been a fixture in global media news cycles for the past six years. LAPTOP is a fungible, freely transferable, non-yield-bearing ERC-20 token on Base. As a memecoin, LAPTOP has no utility, but incorporates two novel distribution mechanics designed to promote long-term community growth: a large community airdrop and an event-based supply mechanism.

Hunter Biden's Laptop

The community is focused on the rapid collapse of the $LAPTOP.X meme coin, with many traders labeling the event a "rug pull" after the token lost nearly all its value shortly after launch. While some participants express frustration over significant financial losses, others are using the situation to debate broader concerns about political meme coins and the lack of regulation in the crypto market.

Select Sector SPDR Trust (The) - State Street Financial Select Sector SPDR ETF

Financial Select Sector SPDR Fund

Financials are trending as investors weigh strong earnings momentum from major banks against broader concerns regarding elevated bond yields and persistent inflation. The sector is seeing significant rotational activity, with traders debating whether its recent price strength and breakout attempts signal durable leadership or a temporary rotation.

Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Novartis AG - ADR

Novartis AG

Novartis shares experienced a significant decline following two failed Phase 3 trial readouts in one week, specifically involving its myotonic dystrophy type 1 drug and its cholesterol-targeting therapy. This double setback has fueled investor concerns regarding the company's recent acquisition strategy and its ability to secure future growth amid an approaching patent cliff.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix shares faced downward pressure amid investor concerns over the impact of announced subscription price increases in the UK and Germany, with some traders debating whether these hikes will drive churn or bolster long-term revenue. While the community remains divided between those viewing the pullback as a buying opportunity for a reliable cash-generating business and others citing competitive risks and stagnant content quality, much of the conversation focuses on technical resistance and the stock's recent price volatility.

GE Vernova, Inc. engages in the electric power industry. It operates through the following segments: Power, Wind, and Electrification. The Power segment offers design, manufacture, and servicing gas, nuclear, hydro, and steam technologies, providing a critical foundation of dispatchable, flexible, stable, and reliable power. The Wind segment manages wind generation technologies, including onshore and offshore wind turbines and blades. The Electrification segment refers to the grid solutions, power conversion, electrification software, and solar and storage solutions technologies required for the transmission, distribution, conversion, storage, and orchestration of electricity from point of generation to point of consumption. The company was founded November 9, 2021 and is headquartered in Cambridge, MA.

GE Vernova Inc.

GE Vernova is drawing significant attention as investors position for the long-term energy infrastructure needs of AI data centers, with many traders highlighting the company's robust gas turbine backlog and grid electrification contracts. While some investors remain cautious about near-term price volatility and potential tariff impacts, sentiment is broadly supported by institutional accumulation and the firm's central role in the global power buildout.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle shares are trending as traders debate the impact of executive chair Larry Ellison canceling a pre-planned stock sale, with bulls viewing the move as a major vote of confidence that removes selling pressure and could fuel a short squeeze. Others remain cautious, pointing to ongoing AI infrastructure spending, high debt levels, and general market skepticism surrounding the sustainability of recent earnings-driven gains.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Biocryst Pharmaceuticals is facing investor frustration as the stock continues to underperform relative to the broader biotech sector, with participants citing concerns over competition from Pharvaris's HAE treatments and management's capital allocation strategy. Traders are debating the merits of a potential share buyback versus further asset acquisitions while expressing ongoing disappointment with the company's lack of stock price appreciation.

Fabrinet engages in the provision of optical packaging and precision optical, electro-mechanical, and electronic manufacturing services to original equipment manufacturers (OEMs). The firm's services include process design and engineering, advanced optical packaging, printed circuit board assembly and test, new product introduction, supply chain and inventory management, and customized glass and crystal optics fabrication. The company was founded by David Thomas Mitchell on August 12, 1999 and is headquartered in George Town, Cayman Islands.

Fabrinet

Fabrinet is experiencing heightened volatility and downward price pressure despite strong financial fundamentals and earnings beats, with traders expressing frustration over the persistent decline. The community is divided between those viewing the pullback as a buying opportunity given the company's role in the AI data center infrastructure supply chain and those concerned by negative free cash flow and broader market sentiment.

Nokia Oyj engages in the provision of network infrastructure, technology, and software services. It operates through the following segments: Mobile Networks, Network Infrastructure, Cloud and Network Services, and Nokia Technologies. The Mobile Networks segment offers technologies for Radio Access Networks (RAN) as well as Microwave Radio Links (MWR) for transport networks. The Network Infrastructure serves communication service providers, enterprises, webscales and public sector customers. The Cloud and Network Services segment builds around software and the cloud and is focused on driving leadership in cloud-native software and as-a-service delivery models, as demand for critical networks accelerates; and with strong market positions in communications software, private wireless networks, and cognitive (or intelligent) services. The Nokia Technologies segment, building on decades of innovation and R&D leadership in technologies used in virtually all mobile devices used today, is expanding the Nokia patent licensing business, reintroducing the Nokia brand to smartphones through brand licensing, and establishing a technology licensing business. The company was founded by Fredrik Idestam in 1865 and is headquartered in Espoo, Finland.

Nokia Corp - ADR

Nokia Corp

Nokia is trending as traders speculate on potential upside from its upcoming inclusion in the Euro STOXX 50 index and ongoing partnerships in AI infrastructure, with some investors betting on a recovery toward previous highs. Despite this optimism, sentiment remains divided, as others express frustration over the stock's sluggish price action and ongoing concerns regarding heavy share float and broader sector headwinds.

Global X Funds - Global X Dow 30 Covered Call ETF

Global X Dow 30 Covered Call ETF

Discussion regarding the DJIA is fragmented, centering on broad concerns about U.S. economic stability, inflationary pressures, and the potential impact of global geopolitical tensions on energy costs and market volatility. Traders also frequently debate the influence of political figures and government spending on market performance while maintaining divergent views on the outlook for various sectors like tech and energy.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Roche Gets FDA Priority Tag for Enspryng in Rare Autoimmune Disorder

RHHBY's sBLA for Enspryng wins FDA priority tag for myelin oligodendrocyte glycoprotein antibody-associated disease. A decision is due on Jan. 10, 2027.

Novartis' Del-desiran Fails Late-Stage DM1 Study, Shares Fall

NVS' del-desiran fails the HARBOR study's primary endpoint, adding to recent pipeline setbacks as investors await next steps.

FDA Accepts & Gives Priority Review to Intellia's BLA for HAE Drug

NTLA's BLA for lonvo-z wins FDA priority review for the treatment of HAE. A decision from the agency is expected by March 10, 2027.

ABBV's Etentamig Meets Goals in Phase III Multiple Myeloma Study

AbbVie's etentamig meets key phase III goals in multiple myeloma, improving response rates and progression-free survival versus standard therapies.

TEVA's TEV '408 Meets Goal in Phase IIa Celiac Disease Study

Teva's TEV '408 meets its phase IIa celiac disease goal, preventing gluten-induced intestinal damage and showing a favorable safety profile.

QURE Submits Application for Gene Therapy for Huntington's Disease

QURE seeks accelerated FDA approval for AMT-130, with Priority Review and a U.K. filing adding momentum to its regulatory push.

Novartis' Remibrutinib Delivers Positive Results in Late-Stage MS Studies

Novartis' remibrutinib delivers positive phase III RMS results, reducing relapse rates versus Aubagio and supporting plans for global regulatory approvals.

GSK to Advance mRNA Influenza Vaccine Into Phase III Development

GSK to advance its mRNA flu vaccine into phase III after phase II study has shown stronger immune responses and good tolerability.

OCGN Advances Gene Therapy OCU410 In Phase III for Geographic Atrophy

Ocugen moves OCU410 into phase III for geographic atrophy, with FDA-aligned study plans. The company expects to file a BLA for OCU410 in 2028.

Axsome Begins Phase III Study on AXS-05 for Smoking Cessation

AXSM begins dosing in the phase III SUMMIT study investigating AXS-05 for treating smoking cessation in adults.

Anika Therapeutics, Inc. is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Its products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical, ophthalmic and veterinary. The company's main focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management, Regenerative Solutions, Sports Medicine and Arthrosurface Joint Solutions, and its products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika Therapeutics was founded in 1992 and is headquartered in Bedford, MA.

Anika Therapeutics Inc.

These 2 Biotech Stocks Hit New 52-Week Highs Today – And CORT Clocked Its Best Day In Nearly 16 Months

Equity

Neutral Sentiment

President Trump has promised to issue a $5,000 "dividend" check to every adult American citizen if the Republican Party wins control of both the House and the Senate in the upcoming midterm elections, though the proposal would require congressional approval and follows his earlier $2,000 tariff-dividend plan, which stalled after the Supreme Court struck down much of his tariff authority. Do you think the $5,000 dividend check actually happens? Vote and explain your reasoning in the comments.

Trump has pledged a $5,000 &quot;dividend&quot; check to every adult American citizen if Republicans win control of both the House and Senate in the midterms. Do you think it actually happens?

Stocktwits

Trump has pledged a $5,000 "dividend" check to every adult American citizen if Republicans win control of both the House and Senate in the midterms. Do you think it actually happens?

Current Price	$20.86
Prev Close	$20.99
Open	$21.25
Dividend Yield	0.00%
50-Day Moving Average	$18.85
Beta	0.87
Avg. Volume	139,232.63
PE Ratio	-76.13

52-Week High	$22.88
52-Week Low	$8.56
Market Capitalization	$279.17M
EPS (Annual)	-$0.7588
Price to Book	2.03
Revenue Per Employee	$480,080.85

Feed

News

Sentiment

Earnings

Fundamentals

Info

ANIK Fundamentals